4th Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for BAXTER HEALTHCARE CORPORATION
Income
$40,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Corporate tax issues, including deferral and device tax Tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXANDER DAHL | — |
| MICHAEL B LEVY | — |
Health Issues HCR
Healthcare reform In-home dialysis H.R. 1130/S.598 - The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 FDA Reform - 21st Century Cures Act Availability of medical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATE MCCANLESS BLANKENBURG | — |
| LAURA JOHNSON BOLLIER | — |
| ALEXANDER DAHL | — |
| MICHAEL B LEVY | — |
| BRIAN WILD | — |
Medicare/Medicaid MMM
Funding issues for Medicare Part B 340 B drug discount program
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATE MCCANLESS BLANKENBURG | — |
| LAURA JOHNSON BOLLIER | — |
| ALEXANDER DAHL | — |
| MICHAEL B LEVY | — |
Trade (domestic/foreign) TRD
Trade Promotion Authority Trans-Pacific Partnership
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATE MCCANLESS BLANKENBURG | — |
| ALEXANDER DAHL | — |
| MICHAEL B LEVY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.